Brief: Trevena Reports Q3 Loss Per Share $0.09

Trevena

04/11/2019 13:59

Nov 4 (Reuters) - Trevena Inc  TRVN.O :
    * TREVENA REPORTS THIRD QUARTER 2019 RESULTS AND TOPLINE
DATA FROM
MULTI-DOSE HEALTHY VOLUNTEER QT STUDY
    * Q3 LOSS PER SHARE $0.09
    * EXPECTS TO RESUBMIT NDA FOR OLICERIDINE IN Q1 2020
    * ACUTE MIGRAINE PROOF-OF-CONCEPT STUDY FOR TRV250 INITIATED
    * CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES WERE
$44.7
MILLION AS OF SEPTEMBER 30, 2019

Source text for Eikon:  ID:nGNX7QWL6M 
Further company coverage:  TRVN.O 

 ((Briefs@thomsonreuters.com;))